PDCD1 and neoplasm: Soluble PD-1 transferred via eukaryotic expression plasmid was shown to increase T cell activation, cytotoxicity and tumor reduction via blocking of PD-L1 and PD-L2 expressed on tumor cells and/or DCs (161–163).